Abstract
Atrial fibrillation (AF) catheter ablation is a well-known treatment option for patients with drug refractory AF. The increasing number of electrophysiology laboratories able to perform this procedure will create in the next years an economic issue, which each cardiac electrophysiologist will have to face with. Identification of predictors of recurrence of AF after catheter ablation is therefore of primary importance to reduce health costs and improve long-term results of this intervention. The aim of this review is to give a brief overview on what have been published already in the literature on the topic and henceforth to increase the awareness of cardiac electrophysiophysiologists on the importance of selection of the right candidates to this intervention.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
